[1]Visser BC, Muthusamy VR, Yeh BM, et al.Coakley FV, WayLW.Diagnostic evaluation of cystic pancreatic lesions[J].HPB (Oxford) 2008, 10 (1) ∶63-69.
|
[2]Hamilton SR, Aaltonen LA.World Health Organization Classifica-tion of Tumours.Tumours of the Digestive System[J].Lyon:IARCPress, 2000, 234–240.
|
[3]Heywood G, van Heerden JA.Cystic tumors of the pancreas[J].Mayo Clinic Gastrointestinal Surgery, 2003, 10∶351-362.
|
[4]Sarr MG, Murr M, Smyrk TC, et al.Primary cystic neoplasms ofthe pancreas.Neoplastic disorders of emerging importance-currentstate-of-the-art and unanswered questions[J].J GastrointestSurg, 2003, 7 (3) ∶417-428.
|
[5]Basturk O, Coban I, Adsay NV.Pancreatic cysts:pathologic clas-sification, differential diagnosis, and clinical implications[J].Arch Pathol Lab Med, 2009, 133 (3) ∶423-438.
|
[6]Brugge WR, Lauwers GY, Sahani D.Cystic Neoplasms of the Pan-creas[J].N Engl J Med, 2004, 351∶1218-1226.
|
[7]Sabiston Textbook of Surgery, 18th ed., Maingot's Abdominal Oper-ations 11th.
|
[8]Ng DZ, Goh BK, Tham EH, et al.Cystic neoplasms of the pancre-as:current diagnostic modalities and management[J].Ann AcadMed Singapore, 2009, 38 (3) ∶251-259.
|
[9]Le Borgne J, de Calan L, Partensky C.Cystadenomas and cystade-nocarcinomas of the pancreas:a multiinstitutional retrospective stud-y of 398 cases.French Surgical Association[J].Ann Surg, 1999, 230∶152-161.
|
[10]Pike CM, van Heerden JA, Colby TV, et al.The spectrum of se-rous cystadenoma of the pancreas:Clinical, pathological, and surgi-cal aspects[J].Ann Surg, 1992, 215 (2) ∶132-139.
|
[11]Matsumoto T, Hirano S, Yada K, et al.Malignant serous cystic ne-oplasm of the pancreas:report of a case and review of the literature[J].J Clin Gastroenterol, 2005, 39 (3) ∶253-256.
|
[12]Megibow AJ, Lombardo FP, Guarise A, et al.Cystic pancreaticmasses:Cross-sectional imaging observations and serial follow-up[J].Abdom Imaging, 2001, 26 (6) ∶640-647.
|
[13]Curry CA, Eng J, Horton KM, et al.CT of primary cystic pancreat-ic neoplasms:can CT be used for patient triage and treatment?[J]AJR Am J Roentgenol, 2000, 175 (1) ∶99-103.
|
[14]Warshaw AL, Rutledge PL.Cystic tumors mistaken for pancreaticpseudocysts[J].Ann Surg, 1987, 205 (4) ∶393-398.
|
[15]Goh BK, Tan YM, Chung YF, et al.A review of mucinous cysticneoplasms of the pancreas defined by ovarian-type stroma:clinico-pathological features of 344 patients[J].World J Surg, 2006, 30 (12) ∶2236-2245.
|
[16]Kiely JM, Nakeeb A, Komorowski RA, et al.Cystic pancreatic ne-oplasms:enucleate or resect?[J]J Gastrointest Surg, 2003, 7 (7) ∶890–897.
|
[17]Ohhashi K, Murakami Y, Takekoshi T.Four cases of mucin-pro-ducing cancer of the pancreas on specific findings of the papilla Va-ter[J].Prog Dig Endosc, 1982, 20∶348-351.
|
[18]Salvia R, Fernández-del Castillo C, Bassi C, et al.Main-ductintraductal papillary mucinous neoplasms of the pancreas:clinicalpredictors of malignancy and long-term survival followingresection[J].Ann Surg, 2004, 239 (5) ∶678-685.
|
[19]Sohn TA, Yeo CJ, Cameron JL, et al.intraductal papillary mucin-ous neoplasms of the pancreas:an updated experience[J].AnnSurg, 2004, 239 (6) ∶788-797.
|
[20]Goh BKP, Tan YM, Cheow PC, et al.Cystic neoplasms of the pan-creas with mucin-production[J].EJSO, 2005, 31 (3) ∶282-287.
|
[21]Tanaka T, Chari S, Adsay V, et al.International consensus guide-lines for management of intraductal papillary mucinous neoplasmsand mucinous cystic neoplasms of the pancreas[J].Pancreatology, 2006, 6 (1-2) 17-32.
|
[22]Pelaez-Luna M, ChariST, Smyrk TC, et al.Do consensus indica-tions for resection in branch duct intraductal papillary mucinous neo-plasm predict malignancy?A study of 147 patients[J].Am J Gas-troenterol, 2007, 102 (8) ∶1759-1764.
|
[23]Woo SM, Ryu JK, Lee SH, et al.Branch duct intraductal papillarymucinous neoplasms in a retrospective series of 190 patients[J].Bri J Surg, 2009, 96 (4) ∶405-411.
|
[24]Frantz VK.Papillary tumors of the pancreas:Benign or malignant?Tumors of the pancreas.Atlas of Tumor Pathology[M].WashingtonDC:Armed Forces Institute of Pathology, 1959∶32-33.
|
[25]Ng KH, Tan PH, Thng CH, et al.Solid pseudopapillary tumour ofthe pancreas[J].Aust N Z J Surg, 2003, 73 (6) ∶410-415.
|
[26]Goh BK, Tan YM, Cheow PC, et al.Solid pseudopapillary neo-plasms of the pancreas:an updated experience[J].J Surg Oncol, 2007, 95 (8) ∶640-644.
|
[1] | Yan WANG, Fujie ZHANG. Research advances in antiviral drugs for the treatment of hepatitis D[J]. Journal of Clinical Hepatology, 2023, 39(4): 776-784. doi: 10.3969/j.issn.1001-5256.2023.04.007 |
[2] | Siwen PENG, Guiwen GUAN, Ting ZHANG, Fengmin LU, Jia LIU, Xiangmei CHEN. Effect of cyclin D1 on HBV transcription and replication[J]. Journal of Clinical Hepatology, 2023, 39(2): 316-324. doi: 10.3969/j.issn.1001-5256.2023.02.010 |
[3] | Xueli YANG, Jianhua XUE, Tianyang CHEN, Jian PING, Tianlu HOU, Jianjie CHEN, Yang CHENG. Effect of atractylone on the viability and apoptosis of hepatoma HepG2 cells and related mechanism[J]. Journal of Clinical Hepatology, 2021, 37(11): 2589-2594. doi: 10.3969/j.issn.1001-5256.2021.11.020 |
[4] | Xiajie WEN, Guixin LI, Jie LI, Huiying RAO, Jidong JIA, Fengmin LU. Interaction between hepatitis B virus replication and lipid metabolism in patients with chronic hepatitis B and NAFLD[J]. Journal of Clinical Hepatology, 2021, 37(7): 1495-1500. doi: 10.3969/j.issn.1001-5256.2021.07.002 |
[5] | Xiong Fang, Gao Yao, Ma YanPin, Yu LeLe, Tan BingQin, Bao XuLi, Lu: Jun. Effect of interferon-α and thymopentin on the mRNA expression of APOBEC3A and APOBEC3B in HepG2.2.15 cells[J]. Journal of Clinical Hepatology, 2020, 36(1): 76-79. doi: 10.3969/j.issn.1001-5256.2020.01.017 |
[6] | Li Pei, Liu Yu. Effect of hepatitis B x gene on the expression of major histocompatibility complex class I chain-related gene A-A5. 1,invasion,and migration of HepG2. 2. 15 cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 808-812. doi: 10.3969/j.issn.1001-5256.2020.04.020 |
[7] | Li YingYing, Zhan LiFen, Ceng ZheChao, Xu Shen. Effect of lobaplatin on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(4): 784-788. doi: 10.3969/j.issn.1001-5256.2018.04.018 |
[8] | Qiu Hua, Gao YueQiu, Mao DeWen, Zhou ZhenHua, Long FuLi, Wang MingGang. Construction of HBV whole-genome 1. 3 ploid HepG2 cell model and expression of HBV biomarkers[J]. Journal of Clinical Hepatology, 2017, 33(4): 668-673. doi: 10.3969/j.issn.1001-5256.2017.04.014 |
[9] | Jia XiaoLi, Shi JuanJuan, Feng Ting, Cheng YanAn, Wang Rui, Liu JingKun, Dang ShuangSuo. Effects of guggulsterone on proliferation and apoptosis of HepG2 human hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(6): 452-455. |
[10] | Ke XiaoYu, Wang QiuJing, Yu Yuan, Liu ShenPei, Zhang ChunYan, Chen Yan, Yang Yan, Yang DongLiang. 17-AAG, an inhibitor of heat shock protein 90, down-regulates hepatitis B virus replication[J]. Journal of Clinical Hepatology, 2012, 28(6): 435-438. |
[11] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[12] | Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153. |
[13] | Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884. |
[14] | Jiang XiaoHua, Liu LingLing, Lei Chuang, Zhou QingPing. Effects of hepatitis C virus genotype 1b core protein on the gene expressions of Bax and Bcl-2 in HepG2 cells[J]. Journal of Clinical Hepatology, 2011, 27(5): 511-514. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Xi HongLi, Liu FangFang, Yuan JiaYing, Yu YanYan. Significance and detection of IL-2、IL-4 and IFN-γ in PBMC from patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(6): 627-629. |
[17] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |
[18] | Chen Sheng, Lin ChaoShuang. The relationship between liver function and immune system and viral replication in patients with viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 94-95. |
[19] | Yang XiaoJuan, Wu GuoRong, Lu ZhongHua, Pei Hao, Qian JinJuan. Clinical signification of detecting PreS;antigen for identifying viral replication in patients with HB without HbeAg[J]. Journal of Clinical Hepatology, 2007, 23(5): 340-341. |